Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881750 · ClinicalTrials.gov registry record · NA
Pivotal Response Group Treatment for Parents of Young Children With Autism
A NA study of Autistic Disorder, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT01881750: Completed NA study of Autistic Disorder, sponsored by Stanford University.
NCT01881750 is a NA study of Autistic Disorder that has completed, run by Stanford University. The registered enrollment target is 53 participants, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01881750, a NA study of Autistic Disorder, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism. Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of autism. The purpose of this study is to further examine the effectiveness of teaching pivotal response treatment to parents of children with autism in a group format. To determine the effectiveness of pivotal response training group (PRTG) it will be compared to another parent education group by conducting a randomized controlled 12-week trial.
Primary Outcome
Total frequency of child's utterances during 10 minute videotaped SLO assessment.
Conditions Studied
Interventions
- BEHAVIORAL Pivotal Response Training (PRT)
- BEHAVIORAL Parent Education Group (PEG)
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01881750 record still lists
NCT01881750 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 112-participant average among 27 other Autistic Disorder trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Autistic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Pivotal Response Training (PRT) is the first listed.
NCT01881750 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01881750 about?
NCT01881750 is a clinical study titled "Pivotal Response Group Treatment for Parents of Young Children With Autism". This is a research study examining the effectiveness of pivotal response treatment group (PRTG) in targeting language skills in young children with autism. Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of a...
What is the current status of trial NCT01881750?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2010-07. Estimated completion is 2012-07.
What conditions does trial NCT01881750 study?
This clinical trial studies the following conditions: Autistic Disorder.
What interventions are being tested in trial NCT01881750?
The interventions under investigation include: Pivotal Response Training (PRT) (BEHAVIORAL), Parent Education Group (PEG) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01881750?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01881750 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01881750's enrollment target sits among peer trials
53 17th of 27 higher than 11 of 27 other Autistic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autistic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
-
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia